Bulletin
Investor Alert

London Markets Close in:

Seattle Genetics Inc.

NAS: SGEN

GO
/marketstate/country/us

Market open

/zigman2/quotes/203326163/composite

$

109.96

Change

+1.66 +1.53%

Volume

Volume 187,451

Nov 12, 2019, 10:36 a.m.

Real time quotes

/zigman2/quotes/203326163/composite

Previous close

$ 108.30

$ 109.96

Change

+1.66 +1.53%

Day low

Day high

$107.68

$110.08

Open
Open: 108.67

52 week low

52 week high

$51.50

$109.72

Open

Market cap

$18.56B

Average volume

1.01M

P/E ratio

N/A

Rev. per Employee

$502,842

EPS

-1.87

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sgen

MarketWatch News on SGEN

  1. Seattle Genetics stock up 14% on news of positive trial of breast cancer treatment

    8:39 a.m. Oct. 21, 2019

    - Ciara Linnane

  2. Four stocks that are nearing key breakouts

    2:23 p.m. Oct. 16, 2019

    - Harry Boxer

  3. Charting a shaky October start, S&P 500 challenges key support

    11:49 a.m. Oct. 1, 2019

    - Michael Ashbaugh

  4. Charting a shaky October start, S&P 500 presses key support (2,960)

    11:15 a.m. Oct. 1, 2019

    - Michael Ashbaugh

  5. Atara Biotherapeutics Stock Falls After Goldman Downgrade

    9:50 a.m. Sept. 27, 2019

    - Barron's Online

  6. Seattle Genetics upgraded to outperform from perform at Oppenheimer

    7:37 a.m. Sept. 12, 2019

    - Tomi Kilgore

  7. Seattle Genetics started at hold with $79 stock price target at Deutsche Bank

    1:19 p.m. July 18, 2019

    - Tomi Kilgore

  8. Seattle Genetics started at hold with $70 stock price target at Stifel Nicolaus

    6:28 a.m. April 11, 2019

    - Tomi Kilgore

  9. Seattle Genetics stock price target cut to $92 from $97 at SVB Leerink

    8:29 a.m. Feb. 8, 2019

    - Tomi Kilgore

  10. Immunomedics Chairman Buys $19M More in Stock

    6:19 a.m. June 22, 2018

    - Barron's Online

  11. Engaged Capital Seeks Seats on Aratana Therapeutics Board

    8:08 p.m. May 4, 2018

    - Barron's Online

  12. Seattle Genetics upgraded to overweight from neutral at J.P. Morgan

    8:16 a.m. Feb. 14, 2018

    - Tomi Kilgore

  13. Lattice Semiconductor in Talks With Lion Point Capital

    11:21 p.m. Feb. 9, 2018

    - Barron's Online

  14. Seattle Genetics May See ‘Significant Upside’

    12:04 p.m. Oct. 25, 2017

    - Barron's Online

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sgen

Other News on SGEN

  1. 4 RNA Therapy Stocks For A Biotech Portfolio

    2:20 p.m. Nov. 7, 2019

    - Seeking Alpha

  2. Seattle Genetics (SGEN) Q3 Loss Widens, Revenues Top Mark

    12:29 p.m. Oct. 30, 2019

    - Zacks.com

  3. Notable earnings after Tuesday’s close

    5:35 p.m. Oct. 28, 2019

    - Seeking Alpha

  4. Merrill Lynch Keeps a Sell Rating on Seattle Genetics (SGEN)

    5:22 a.m. Oct. 23, 2019

    - SmarterAnalyst

  5. Healthcare And Biotechs Struggle, But Opportunity Ahead

    2:24 a.m. Oct. 23, 2019

    - Seeking Alpha

  6. Seattle Genetics (SGEN) Receives a Buy from H.C. Wainwright

    7:13 a.m. Oct. 22, 2019

    - SmarterAnalyst

  7. Seattle Genetics (SGEN) Receives a Buy from J.P. Morgan

    7:13 a.m. Oct. 22, 2019

    - SmarterAnalyst

  8. 5 Top Stock Trades for Tuesday: PINS, BAC, TWTR

    3:57 p.m. Oct. 21, 2019

    - InvestorPlace.com

  9. Seattle Genetics (SGEN) Gets a Hold Rating from Cowen & Co.

    12:52 p.m. Oct. 21, 2019

    - SmarterAnalyst

  10. BNTX, COTY, INFY, MFGP and SGEN among midday movers

    12:38 p.m. Oct. 21, 2019

    - Seeking Alpha

  11. Big Step Forward in HER2-Positive Breast Cancer Trial

    9:59 a.m. Oct. 21, 2019

    - 247WallSt.com

  12. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/sgen

Press Releases on SGEN

  1. AvantGen Appoints Chief Business Officer

    6:09 p.m. Nov. 5, 2019

    - BusinessWire - BZX

  2. Seattle Genetics Reports Third Quarter 2019 Financial Results

    4:02 p.m. Oct. 29, 2019

    - BusinessWire - BZX

  3. Monday's ETF with Unusual Volume: VOT

    1:16 p.m. Oct. 21, 2019

    - MarketNewsVideo.com

  4. Antibody Drug Conjugate Market Size to Hit $ 10.1 Bn by 2026

    7:27 a.m. Oct. 18, 2019

    - Market Prediction

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.